The Endothelial Glycocalyx as a Target of Excess Soluble Fms-like Tyrosine Kinase-1.
endothelial dysfunction
endothelial glycocalyx
endothelial injury
heparin
monocyte adhesion
soluble fms-like tyrosine kinase-1 (sFlt-1)
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Mar 2023
11 Mar 2023
Historique:
received:
13
02
2023
revised:
08
03
2023
accepted:
09
03
2023
medline:
30
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
Soluble fms-like tyrosine kinase-1 (sFlt-1) is a secreted protein that binds heparan sulfate expressed on the endothelial glycocalyx (eGC). In this paper we analyze how excess sFlt-1 causes conformational changes in the eGC, leading to monocyte adhesion, a key event triggering vascular dysfunction. In vitro exposure of primary human umbilical vein endothelial cells to excess sFlt-1 decreased eGC height and increased stiffness as determined by atomic force microscopy (AFM). Yet, structural loss of the eGC components was not observed, as indicated by Ulex europaeus agglutinin I and wheat germ agglutinin staining. Moreover, the conformation observed under excess sFlt-1, a collapsed eGC, is flat and stiff with unchanged coverage and sustained content. Functionally, this conformation increased the endothelial adhesiveness to THP-1 monocytes by about 35%. Heparin blocked all these effects, but the vascular endothelial growth factor did not. In vivo administration of sFlt-1 in mice also resulted in the collapse of the eGC in isolated aorta analyzed ex vivo by AFM. Our findings show that excess sFlt-1 causes the collapse of the eGC and favors leukocyte adhesion. This study provides an additional mechanism of action by which sFlt-1 may cause endothelial dysfunction and injury.
Identifiants
pubmed: 36982455
pii: ijms24065380
doi: 10.3390/ijms24065380
pmc: PMC10049398
pii:
doi:
Substances chimiques
Vascular Endothelial Growth Factor Receptor-1
EC 2.7.10.1
Vascular Endothelial Growth Factor A
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : SE2824/3-1
Organisme : Deutsche Forschungsgemeinschaft
ID : KFO 342 - ZA428/18-1
Références
J Am Heart Assoc. 2019 Feb 19;8(4):e010647
pubmed: 30764695
Biotechnol Appl Biochem. 2001 Dec;34(3):199-204
pubmed: 11730488
Sci Rep. 2018 May 15;8(1):7581
pubmed: 29765073
Cardiovasc Res. 2011 Feb 15;89(3):671-9
pubmed: 21139021
Biophys J. 2019 Feb 19;116(4):694-708
pubmed: 30736980
J Am Soc Nephrol. 2009 Oct;20(10):2235-45
pubmed: 19608702
Am J Hematol. 2020 Aug;95(8):E188-E191
pubmed: 32472588
PLoS One. 2013 Nov 20;8(11):e80905
pubmed: 24278345
J Cell Sci. 2003 Sep 1;116(Pt 17):3479-89
pubmed: 12865438
Obstet Gynecol. 2007 Jun;109(6):1368-74
pubmed: 17540809
Trends Pharmacol Sci. 2017 Apr;38(4):322-338
pubmed: 28214012
Cell. 1997 Nov 28;91(5):695-704
pubmed: 9393862
Sci Rep. 2017 Apr 13;7:46476
pubmed: 28406245
J Am Soc Nephrol. 2012 Nov;23(11):1900-8
pubmed: 23085635
PLoS One. 2012;7(7):e41520
pubmed: 22844486
J Biol Chem. 2005 Mar 18;280(11):10234-43
pubmed: 15632175
Biochem Biophys Res Commun. 1999 Nov 2;264(3):730-4
pubmed: 10544000
J Immunol. 2015 Aug 1;195(3):1152-61
pubmed: 26101325
Phys Rev Lett. 2018 May 11;120(19):198001
pubmed: 29799224
Blood. 2008 Apr 1;111(7):3479-88
pubmed: 18184864
J Chem Inf Model. 2021 Aug 23;61(8):3891-3898
pubmed: 34278794
Front Physiol. 2020 Jun 18;11:684
pubmed: 32625119
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Clin Invest. 2016 Jul 1;126(7):2561-74
pubmed: 27270170
Structure. 2017 Feb 7;25(2):341-352
pubmed: 28111021
FEBS J. 2022 Jan;289(1):183-198
pubmed: 34252269
Biochem Biophys Res Commun. 1996 Sep 13;226(2):324-8
pubmed: 8806634
Int J Mol Sci. 2021 Jan 19;22(2):
pubmed: 33478148
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):272-9
pubmed: 25538208
Science. 2021 Aug 20;373(6557):871-876
pubmed: 34282049
Front Physiol. 2011 Oct 04;2:62
pubmed: 22007175
J Vis Exp. 2015 Jul 23;(101):e53057
pubmed: 26273955
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2972-4
pubmed: 21979436
Sci Rep. 2019 Dec 3;9(1):18209
pubmed: 31796790
Circulation. 2011 Dec 6;124(23):2543-53
pubmed: 22082677
Sci Rep. 2017 Aug 25;7(1):9444
pubmed: 28842629
Front Immunol. 2021 Nov 30;12:789142
pubmed: 34917096
Pflugers Arch. 2011 Oct;462(4):519-28
pubmed: 21796337
Am J Physiol Cell Physiol. 2021 Feb 1;320(2):C216-C224
pubmed: 33326314
Nanomedicine. 2015 Aug;11(6):1521-30
pubmed: 25881741
Adv Colloid Interface Sci. 2014 Jun;208:161-76
pubmed: 24674656
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Basic Res Cardiol. 2015 May;110(3):30
pubmed: 25893874
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10705-9
pubmed: 8248162
Circ Res. 2011 Apr 29;108(9):1063-70
pubmed: 21415391
J Immunol. 1989 Mar 15;142(6):1970-6
pubmed: 2784145
Atherosclerosis. 2014 Jun;234(2):335-43
pubmed: 24727235
Kidney Int. 2020 Mar;97(3):502-515
pubmed: 32008804
J Am Coll Cardiol. 2011 Jul 19;58(4):386-94
pubmed: 21757116
Biol Sex Differ. 2020 Jun 29;11(1):34
pubmed: 32600401
PLoS One. 2014 Jan 21;9(1):e85258
pubmed: 24465515
Int J Mol Sci. 2022 Dec 16;23(24):
pubmed: 36555698
Cell. 2012 Oct 12;151(2):384-99
pubmed: 23063127
J Cell Biol. 1993 Mar;120(6):1371-80
pubmed: 8449983
J Clin Med Res. 2018 Sep;10(9):700-706
pubmed: 30116440
Kidney Int. 2019 May;95(5):1091-1102
pubmed: 30824181
Nature. 2006 Oct 26;443(7114):993-7
pubmed: 17051153
J Am Soc Nephrol. 2021 Aug;32(8):1853-1863
pubmed: 34155060
Am J Pathol. 2020 Apr;190(4):732-741
pubmed: 32035884
J Biol Chem. 2004 Oct 1;279(40):41734-43
pubmed: 15292271
J Clin Invest. 2003 Mar;111(5):649-58
pubmed: 12618519
Antioxid Redox Signal. 2019 Mar 1;30(7):945-959
pubmed: 29433330
Int J Biochem Cell Biol. 2001 Apr;33(4):409-20
pubmed: 11312109
J Matern Fetal Neonatal Med. 2022 Dec;35(25):7466-7470
pubmed: 34238103
Cell Mol Bioeng. 2016 Aug 25;10(1):102-113
pubmed: 31719852
Front Med (Lausanne). 2022 May 09;9:894633
pubmed: 35615097
Front Pharmacol. 2020 Jan 21;10:1568
pubmed: 32038245